Weight-loss stimulants and “energy” supplements can cause sympathomimetic toxicity, hyperthermia, arrhythmias, agitation, and seizures. Many products are...
At the Bedside
- Common agents: caffeine, ephedra-like compounds, synephrine, yohimbine, amphetamine-like adulterants, “fat burners,” pre-workout supplements.
- Presentation: agitation, anxiety, tremor, tachycardia, hypertension, mydriasis, diaphoresis, chest pain, hyperthermia, psychosis, seizures.
- Workup:
- Vitals including core temperature.
- ECG for tachyarrhythmias, ischemia, QT/QRS issues.
- Glucose, electrolytes, CK, creatinine, troponin if chest pain, pregnancy test when relevant.
- Consider co-ingestants and serotonin syndrome if serotonergic symptoms are present.
- Management:
- Sedation is key: benzodiazepines first-line.
- IV fluids, cooling if hyperthermic, treat rhabdomyolysis.
- Avoid pure beta-blocker monotherapy in severe sympathomimetic toxicity; use caution with ischemia and consult toxicology.
- If chest pain/vasospasm, manage as stimulant-associated ischemia; nitroglycerin may help selected patients.
- Disposition:
- Discharge only if symptoms fully resolve, vitals normalize, and no end-organ injury.
- Admit for hyperthermia, rhabdo, chest pain/ischemia, persistent agitation, seizures, or significant arrhythmias.
Classic Presentation
A 31-year-old woman presents with severe anxiety, tachycardia, and chest tightness after taking multiple “pre-workout” scoops plus an over-the-counter weight-loss pill. She is hypertensive, diaphoretic, and tremulous with sinus tachycardia on ECG. She improves after repeated lorazepam doses, IV fluids, and observation; troponin is negative and symptoms resolve.
Study Directive
- Build a sympathomimetic toxidrome checklist from memory.
- Practice distinguishing stimulant toxicity vs anticholinergic vs serotonin syndrome.
- Review your ED’s preferred benzodiazepine choices and repeat-dosing strategy for agitation.
- Write a one-line social history prompt that asks about pre-workout, weight-loss pills, and energy supplements.
Mechanism Pearl of the Day: Several topics today are fundamentally about
oxygen and energy failure: CO prevents oxygen carriage, cyanide prevents oxygen utilization, DNP forces energy to be lost as heat by uncoupling oxidative phosphorylation, and stimulants/thyroid excess increase metabolic demand until supply fails. In toxicology, always ask whether the problem is
delivery, utilization, or demand.
Key Medications
- Lorazepam: 1–2 mg IV/PO/IM, repeat as needed; titrate to effect.
- Diazepam: 5–10 mg IV, repeat as needed.
- Midazolam: 2–5 mg IV/IM/IN, repeat as needed; often useful for severe agitation.
- Nitroglycerin for stimulant chest pain/vasospasm: dosing depends on formulation; use standard ACS/chest pain protocols if BP allows.
- Active cooling for hyperthermia; no antidote for most stimulant products.
High-Yield Pearls
- Sedation treats the syndrome: calming the CNS lowers catecholamine-driven toxicity.
- Measure temperature: hyperthermia is a major predictor of severe poisoning.
- Ask specifically about supplements: “fat burners” and pre-workouts are often underreported unless directly queried.
Board Question
First-line treatment for agitation and tachycardia in stimulant toxicity is:
- AHaloperidol alone
- BBenzodiazepines
- CPropranolol monotherapy
- DPhysostigmine
Reveal answer
Correct: B
Benzodiazepines are first-line because they reduce central sympathetic outflow, agitation, and seizure risk. Pure beta-blockade is not preferred as initial monotherapy in stimulant toxicity.